Cargando…
Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysis
BACKGROUND: The standard treatment for localised squamous cell carcinoma of the anal canal (SCCAC) is chemoradiotherapy (CRT) with infusional 5-fluorouracil (5-FU) and mitomycin. Because 5-FU and capecitabine have offered similar efficacy in many phase-III trials of solid tumours, studies have teste...
Autores principales: | Souza, Karla T, Pereira, Allan AL, Araujo, Raphael L, Oliveira, Suilane Coelho Ribeiro, Hoff, Paulo M, Riechelmann, Rachel P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221636/ https://www.ncbi.nlm.nih.gov/pubmed/28105070 http://dx.doi.org/10.3332/ecancer.2016.699 |
Ejemplares similares
-
A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment Outcomes
por: Moniz, Camila Motta Venchiarutti, et al.
Publicado: (2021) -
Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal
por: Saint, Angélique, et al.
Publicado: (2019) -
Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study
por: Truelsen, Christina Glismand, et al.
Publicado: (2021) -
Melanoma of the anal canal
por: Parra, Rogerio Serafim, et al.
Publicado: (2010) -
Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
por: Thind, Govin, et al.
Publicado: (2014)